Broad segmental progeroid changes in short-lived Ercc1(-/Δ7) mice - PubMed
doi: 10.3402/pba.v1i0.7219. Epub 2011 Jun 1.
Raoul V Kuiper, Marianne Roodbergen, Joke Robinson, Sisca de Vlugt, Susan W P Wijnhoven, Rudolf B Beems, Liset de la Fonteyne, Piet de With, Ingrid van der Pluijm, Laura J Niedernhofer, Paul Hasty, Jan Vijg, Jan H J Hoeijmakers, Harry van Steeg
Affiliations
- PMID: 22953029
- PMCID: PMC3417667
- DOI: 10.3402/pba.v1i0.7219
Broad segmental progeroid changes in short-lived Ercc1(-/Δ7) mice
Martijn E T Dollé et al. Pathobiol Aging Age Relat Dis. 2011.
Abstract
Genome maintenance is considered a prime longevity assurance mechanism as apparent from many progeroid human syndromes that are caused by genome maintenance defects. The ERCC1 protein is involved in three genome maintenance systems: nucleotide excision repair, interstrand cross-link repair, and homologous recombination. Here we describe in-life and post-mortem observations for a hypomorphic Ercc1 variant, Ercc1(-/Δ7), which is hemizygous for a single truncated Ercc1 allele, encoding a protein lacking the last seven amino acids. Ercc1(-/Δ7) mice were much smaller and median life span was markedly reduced compared to wild-type siblings: 20 and 118 weeks, respectively. Multiple signs and symptoms of aging were found to occur at an accelerated rate in the Ercc1(-/Δ7) mice as compared to wild-type controls, including a decline in weight of both whole body and various organs, numerous histopathological lesions, and immune parameters. Together they define a segmental progeroid phenotype of the Ercc1(-/Δ7) mouse model.
Keywords: C57BL/6; Ercc1; FVB; aging; body weight; cross sectional; genome maintenance; immunosenescense; life span; mouse; organ weight; pathology.
Figures

Life span (A) and mean body weight (B) curves of Ercc1 −/Δ7 and Ercc1 +/+ sibling control mice of the life span cohorts. Mice entered the study at weaning age (3 weeks); deaths before weaning age are not depicted (see text). Ercc1 −/Δ7 males: blue (n=31); Ercc1 −/Δ7 females: green (n=29); Ercc1 +/+ males: red (n=50); and Ercc1 +/+ females: orange (n=51).

Mean total body weights and mean absolute and relative organ weights of Ercc1 −/Δ7 and Ercc1 +/+ sibling control mice of the cross-sectional cohorts (filled symbols and lines) and grouped moribund mice of the life span cohorts, termed ‘end-of-life’ (open symbols). The relative organ weights are expressed as a percentage of the total body weights. The position on the y-axis (age) for the ‘end-of-life’ data is arbitrary to keep it distinct from the cross-sectional data points in the graph layout; mean ages (±SD) in weeks of the end-of-life groups are: Ercc1 −/Δ7 males: 19.6±2.6; Ercc1 −/Δ7 females: 21.0±4.9; Ercc1 +/+ males: 123±22; and Ercc1 +/+ females: 116±20 weeks. The means of the cross-sectional data are based on 4–16 animals or tissues per group; the means of the end-of-life groups are based on 19–40 animals or tissues per group. The error bars represent standard deviations of the means. Ercc1 −/Δ7 males: blue diamonds; Ercc1 −/Δ7 females: green dots; Ercc1 +/+ males: red triangles; and Ercc1 +/+ females: orange inverted triangles.

Mean pathology scores of liver and kidney observations at cross-sectional age groups in Ercc1 −/Δ7 and Ercc1 +/+ mice. A: kidney anisokayosis, B: kidney tubular degeneration, C: liver anisokaryosis, D: liver intranuclear inclusions, and E: liver lipofuscin. Means are based on 5–31 organs per genotype and age group (males and females combined). The bars indicate the 95% confidence intervals. Ercc1 −/Δ7: blue dots; Ercc1 +/+: red triangles. F: Calculated age to reach lipofuscin pathology score for male and female Ercc1 −/Δ7 and Ercc1 +/+ mice. Modeled by PROAST, with exponential model 2: y=a exp(bx) as selected model, based on a total of 115 observations. Age at score 1 could not be calculated. Ercc1 −/Δ7 males: blue diamonds; Ercc1 −/Δ7 females: green dots; Ercc1 +/+ males: red triangles; and Ercc1 +/+ females: orange inverted triangles.

Examples of histopathology in aging male Ercc1 +/+ and Ercc1 −/Δ7 mice. Liver of Ercc1 +/+, 110 weeks (A). Marked scattered anisokaryosis and karyomegaly (larger nuclei); note general absence of nuclear inclusions. Compare to liver of 19 weeks old Ercc1 −/Δ7 mutant (B): marked anisokaryosis and marked intranuclear cytoplasmic inclusions/invaginations. Kidney of 110 weeks old Ercc1 +/+ mouse shows rare karyomegaly (C) compared to 19 weeks old Ercc1 −/Δ7 mutant (D). Bone marrow fatty infiltration and atrophy is present in 120 weeks old Ercc1 +/+ (E) but even more pronounced in Ercc1 −/Δ7 mutant at 20 weeks (F).

Lymphocyte subset distributions in Ercc1 −/Δ7 and Ercc1 +/+ mice at cross-sectional age groups. A: T-cell distribution in the thymus as ratios of immature, stage II cells over mature stage III cells. B: Percentage of natural killer cells among CD45 positive splenocytes. C: Ratio of naïve over memory CD4 positive T-cells in spleen. D: Ratio of naïve over memory CD8 positive T-cells in spleen. All symbols display means of n=5, except in graph A at 96 weeks, which represent a single individual value for each sex (see text for details). The error bars indicate standard deviations. Ercc1 −/Δ7 males: blue diamonds; Ercc1 −/Δ7 females: green dots; Ercc1 +/+ males: red triangles; and Ercc1 +/+ females: orange inverted triangles.
Similar articles
-
Kim DE, Dollé MET, Vermeij WP, Gyenis A, Vogel K, Hoeijmakers JHJ, Wiley CD, Davalos AR, Hasty P, Desprez PY, Campisi J. Kim DE, et al. Aging Cell. 2020 Mar;19(3):e13072. doi: 10.1111/acel.13072. Epub 2019 Nov 18. Aging Cell. 2020. PMID: 31737985 Free PMC article.
-
van Beek AA, Sovran B, Hugenholtz F, Meijer B, Hoogerland JA, Mihailova V, van der Ploeg C, Belzer C, Boekschoten MV, Hoeijmakers JH, Vermeij WP, de Vos P, Wells JM, Leenen PJ, Nicoletti C, Hendriks RW, Savelkoul HF. van Beek AA, et al. Front Immunol. 2016 Oct 7;7:408. doi: 10.3389/fimmu.2016.00408. eCollection 2016. Front Immunol. 2016. PMID: 27774093 Free PMC article.
-
Whole chromosome aneuploidy in the brain of Bub1bH/H and Ercc1-/Δ7 mice.
Andriani GA, Faggioli F, Baker D, Dollé ME, Sellers RS, Hébert JM, Van Steeg H, Hoeijmakers J, Vijg J, Montagna C. Andriani GA, et al. Hum Mol Genet. 2016 Feb 15;25(4):755-65. doi: 10.1093/hmg/ddv612. Epub 2015 Dec 17. Hum Mol Genet. 2016. PMID: 26681803 Free PMC article.
-
Interstrand crosslink repair: can XPF-ERCC1 be let off the hook?
Bergstralh DT, Sekelsky J. Bergstralh DT, et al. Trends Genet. 2008 Feb;24(2):70-6. doi: 10.1016/j.tig.2007.11.003. Epub 2008 Jan 14. Trends Genet. 2008. PMID: 18192062 Review.
-
Physiological consequences of defects in ERCC1-XPF DNA repair endonuclease.
Gregg SQ, Robinson AR, Niedernhofer LJ. Gregg SQ, et al. DNA Repair (Amst). 2011 Jul 15;10(7):781-91. doi: 10.1016/j.dnarep.2011.04.026. Epub 2011 May 25. DNA Repair (Amst). 2011. PMID: 21612988 Free PMC article. Review.
Cited by
-
Chronic Sildenafil Treatment Improves Vasomotor Function in a Mouse Model of Accelerated Aging.
Golshiri K, Ataei Ataabadi E, Brandt R, van der Pluijm I, de Vries R, Danser J, Roks A. Golshiri K, et al. Int J Mol Sci. 2020 Jun 30;21(13):4667. doi: 10.3390/ijms21134667. Int J Mol Sci. 2020. PMID: 32630010 Free PMC article.
-
Nucleotide excision DNA repair is associated with age-related vascular dysfunction.
Durik M, Kavousi M, van der Pluijm I, Isaacs A, Cheng C, Verdonk K, Loot AE, Oeseburg H, Bhaggoe UM, Leijten F, van Veghel R, de Vries R, Rudez G, Brandt R, Ridwan YR, van Deel ED, de Boer M, Tempel D, Fleming I, Mitchell GF, Verwoert GC, Tarasov KV, Uitterlinden AG, Hofman A, Duckers HJ, van Duijn CM, Oostra BA, Witteman JC, Duncker DJ, Danser AH, Hoeijmakers JH, Roks AJ. Durik M, et al. Circulation. 2012 Jul 24;126(4):468-78. doi: 10.1161/CIRCULATIONAHA.112.104380. Epub 2012 Jun 15. Circulation. 2012. PMID: 22705887 Free PMC article.
-
Golshiri K, Ataabadi EA, Jüttner AA, Snyder GL, Davis RE, Lin A, Zhang L, de Vries R, Garrelds IM, Leijten FPJ, Danser AHJ, Roks AJM. Golshiri K, et al. Front Pharmacol. 2022 Jan 31;12:818355. doi: 10.3389/fphar.2021.818355. eCollection 2021. Front Pharmacol. 2022. PMID: 35173613 Free PMC article.
-
He Y, van Mever M, Yang W, Huang L, Ramautar R, Rijksen Y, Vermeij WP, Hoeijmakers JHJ, Harms AC, Lindenburg PW, Hankemeier T. He Y, et al. Metabolites. 2022 Aug 12;12(8):742. doi: 10.3390/metabo12080742. Metabolites. 2022. PMID: 36005613 Free PMC article.
-
Slow accumulation of mutations in Xpc-/- mice upon induction of oxidative stress.
Melis JP, Kuiper RV, Zwart E, Robinson J, Pennings JL, van Oostrom CT, Luijten M, van Steeg H. Melis JP, et al. DNA Repair (Amst). 2013 Dec;12(12):1081-6. doi: 10.1016/j.dnarep.2013.08.019. Epub 2013 Sep 29. DNA Repair (Amst). 2013. PMID: 24084170 Free PMC article.
References
-
- Hasty P, Campisi J, Hoeijmakers J, van Steeg H, Vijg J. Aging and genome maintenance: lessons from the mouse? Science. 2003;299:1355–59. - PubMed
-
- Melis JP, Wijnhoven SWP, Beems RB, Roodbergen M, van den Berg J, Moon H, et al. Mouse models for xeroderma pigmentosum group A and group C show divergent cancer phenotypes. Cancer Res. 2008;68:1347–53. - PubMed
-
- Wijnhoven SW, Beems RB, Roodbergen M, van den Berg J, Lohman PH, et al. Accelerated aging pathology in ad libitum fed Xpd(TTD) mice is accompanied by features suggestive of caloric restriction. DNA Repair (Amst) 2005;4:1314–24. - PubMed
LinkOut - more resources
Full Text Sources
Molecular Biology Databases